{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:16:30Z","timestamp":1760746590134,"version":"build-2065373602"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Foot"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.foot.2021.101837","type":"journal-article","created":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T13:26:20Z","timestamp":1628601980000},"page":"101837","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Plasma levels of Asymmetric Di Methyl Arginine and endothelial dysfunction in diabetic subjects with neuropathic foot ulcer"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9103-158X","authenticated-orcid":false,"given":"Fady Azmy","family":"Kyrillos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamad","family":"Motawea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Abd-El-Aziz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azza","family":"Al-Bayoumy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Talal","family":"Amer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamdouh","family":"El-Nahas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.foot.2021.101837_bib0005","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/j.jacc.2008.09.055","article-title":"The pathologic continuum of diabetic vascular disease","volume":"53","author":"Orasanu","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.foot.2021.101837_bib0010","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199807233390404","article-title":"Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction","volume":"339","author":"Haffner","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.foot.2021.101837_bib0015","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report","volume":"106","author":"National Cholesterol Education Program (NCEP)","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.foot.2021.101837_bib0020","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S1078-5884(97)80179-7","article-title":"Long-term prognosis for patients with chronic leg ulcers: a prospective cohort study","volume":"13","author":"Nelzen","year":"1997","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.foot.2021.101837_bib0025","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1177\/147323000203000602","article-title":"Is neuropathic ulceration the key to understanding increased mortality due to ischaemic heart disease in diabetic foot ulcer patients? A population approach using a proportionate model","volume":"30","author":"Chammas","year":"2002","journal-title":"J Int Med Res"},{"key":"10.1016\/j.foot.2021.101837_bib0030","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1007\/s00125-012-2673-3","article-title":"The association of ulceration of the foot with cardiovascularand all-cause mortality in patients with diabetes: a meta-analysis","volume":"55","author":"Brownrigg","year":"2012","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.foot.2021.101837_bib0035","first-page":"53","article-title":"What is the major cause of death for diabetic foot ulcer patients and is it related to the type of ulcer? (Abstract)","volume":"17","author":"Chammas","year":"2000","journal-title":"Diabet Med"},{"key":"10.1016\/j.foot.2021.101837_bib0040","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/qjmed\/94.11.623","article-title":"Long-term predictors of coronary artery disease and mortality in type 1 diabetes","volume":"94","author":"Weis","year":"2001","journal-title":"QJM"},{"issue":"2","key":"10.1016\/j.foot.2021.101837_bib0045","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/1479164110366053","article-title":"Asymmetric dimethylarginine as a mediator of vascular dysfunction and a marker of cardiovascular disease and mortality: an intriguing interaction with diabetes mellitus","volume":"7","author":"Anderssohn","year":"2010","journal-title":"Diabet Vasc Dis Res"},{"key":"10.1016\/j.foot.2021.101837_bib0050","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1161\/01.CIR.101.9.948","article-title":"Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction","volume":"101","author":"Suwaidi","year":"2000","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.foot.2021.101837_bib0055","first-page":"469","article-title":"Endothelial dysfunction in diabetic subjects with neuropathic foot ulceration","volume":"54","author":"El-Nahas","year":"2011","journal-title":"Diabetologia"},{"issue":"25","key":"10.1016\/j.foot.2021.101837_bib0060","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1016\/j.jacc.2010.09.001","article-title":"ACCF\/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"56","author":"Greenland","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.foot.2021.101837_bib0065","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/j.1464-5491.2007.02278.x","article-title":"Diabetic neuropathy is closely associated with arterial stiffening and thickness in Type 2 diabetes","volume":"24","author":"Yokoyama","year":"2007","journal-title":"Diabet Med"},{"key":"10.1016\/j.foot.2021.101837_bib0070","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.2337\/dc10-2222","article-title":"Diabetic peripheral neuropathy is associated with increased arterial stiffness without changes in carotid intima-media thickness in type 2 diabetes","volume":"34","author":"Kim","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.foot.2021.101837_bib0075","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.12659\/MSM.892648","article-title":"Arterial stiffness and carotid intima-media thickness in diabetic peripheral neuropathy","volume":"20","author":"Avci","year":"2014","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.foot.2021.101837_bib0080","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2174\/157340310791162659","article-title":"The role of asymmetric dimethylarginine (ADMA) in endothelial dysfunction and cardiovascular disease","volume":"6","author":"Sibal","year":"2010","journal-title":"Curr Cardiol Rev"},{"issue":"12","key":"10.1016\/j.foot.2021.101837_bib0085","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1097\/00005344-199204002-00018","article-title":"Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis","volume":"20","author":"Vallance","year":"1992","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.foot.2021.101837_bib0090","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1373\/clinchem.2006.076711","article-title":"Asymmetrical dimethylarginine independently predicts total cardiovascular mortality in individuals with angiographic coronary artery disease (the Ludwigshafen risk and cardiovascular health study)","volume":"53","author":"Meinitzer","year":"2007","journal-title":"Clin Chem"},{"issue":"3","key":"10.1016\/j.foot.2021.101837_bib0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2006.06.005","article-title":"Asymmetric dimethylarginine is an independent risk factor for coronary heart disease: results from the multicenter Coronary Artery Risk Determination investigating the Influence of ADMA Concentration (CARDIAC) study","volume":"152","author":"Schulze","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.foot.2021.101837_bib0100","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2337\/diacare.27.3.765","article-title":"Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes","volume":"27","author":"Tarnow","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.foot.2021.101837_bib0105","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(01)07184-7","article-title":"Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine","volume":"358","author":"Valkonen","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.foot.2021.101837_bib0110","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1161\/01.ATV.0000242801.38419.48","article-title":"Asymmetric dimethylarginine predicts major adverse cardiovascular events in patients with advanced peripheral artery disease","volume":"26","author":"Mittermayer","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.foot.2021.101837_bib0115","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1016\/S0024-3205(98)00225-2","article-title":"Increased endogenous nitric oxide synthase inhibitor in patients with congestive heart failure","volume":"62","author":"Usui","year":"1998","journal-title":"Life Sci"},{"key":"10.1016\/j.foot.2021.101837_bib0120","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0021-9150(01)00444-0","article-title":"Elevated levels of plasma homocyst(e)ine and asymmetric dimethylarginine in elderly patients with stroke","volume":"158","author":"Yoo","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.foot.2021.101837_bib0125","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1161\/ATVBAHA.108.162768","article-title":"Impact of asymmetric dimethylarginine on mortality after acute myocardial infarction","volume":"28","author":"Zeller","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.foot.2021.101837_bib0130","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/MCA.0b013e328323982f","article-title":"Relationship of baseline plasma ADMA levels to cardiovascular outcomes at 2 years in men with acute coronary syndrome referred for coronary angiography","volume":"20","author":"Cavusoglu","year":"2009","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.foot.2021.101837_bib0135","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/diagnostics1010038","article-title":"Flow-mediated vasodilatation and intima-media thickness in patients with coexisting heart failure and diabetes receiving medical therapy","volume":"1","author":"Andersen","year":"2011","journal-title":"Diagnostics"},{"key":"10.1016\/j.foot.2021.101837_bib0140","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0735-1097(01)01746-6","article-title":"Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the international brachial artery reactivity task force","volume":"39","author":"Corretti","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.foot.2021.101837_bib0145","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/eurheartj\/ehi017","article-title":"Assessment of flow-mediated vasodilatation (FMD) of the brachial artery: effects of technical aspects of the FMD measurement on the FMD response","volume":"26","author":"Bots","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.foot.2021.101837_bib0150","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1136\/hrt.78.1.22","article-title":"Non-invasive measurement of endothelial function: effect or brachial artery dilatation of graded endothelial dependent and independent stimuli","volume":"78","author":"Leeson","year":"1997","journal-title":"Heart"},{"key":"10.1016\/j.foot.2021.101837_bib0155","first-page":"9","volume":"14","author":"Natale","year":"2014","journal-title":"Anadolu Kardiyol Derg"},{"key":"10.1016\/j.foot.2021.101837_bib0160","first-page":"9","article-title":"Dilata\u00e7\u00e3o fluxo-mediada da art\u00e9ria braquial: desenvolvimento da t\u00e9cnica, estudo em pacientes de risco para aterosclerose e em um grupo controle","volume":"9","author":"Regattieri","year":"2006","journal-title":"Rev Bras Ultrason."},{"issue":"12","key":"10.1016\/j.foot.2021.101837_bib0165","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1097\/00004872-200212000-00002","article-title":"Carotid intima-media thickness, arterial stiffness and risk of cardiovascular disease: current evidence","volume":"20","author":"Bots","year":"2002","journal-title":"J Hypertens"},{"issue":"15","key":"10.1016\/j.foot.2021.101837_bib0170","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1001\/archinte.163.15.1787","article-title":"Cardiovascular risk factors and increased carotid intima-media thickness in healthy young adults: the Atherosclerosis Risk in Young Adults (ARYA) Study","volume":"163","author":"Oren","year":"2003","journal-title":"Arch Intern Med"},{"issue":"12","key":"10.1016\/j.foot.2021.101837_bib0175","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1016\/j.bbadis.2013.08.006","article-title":"Endothelial dysfunction \u2014 a major mediator of diabetic vascular disease, BBA","volume":"1832","author":"Sena","year":"2013","journal-title":"Mol Basis Dis"},{"key":"10.1016\/j.foot.2021.101837_bib0180","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1161\/CIRCULATIONAHA.108.765701","article-title":"Endothelial function predicts progression of carotid intima-media thickness","volume":"119","author":"Halcox","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.foot.2021.101837_bib0185","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1053\/meta.2002.33349","article-title":"Metformin treatment lowers asymmeteric dimethylarginine concentrations in patients with type 2 diabetes","volume":"51","author":"Asagami","year":"2003","journal-title":"Metabolism"},{"key":"10.1016\/j.foot.2021.101837_bib0190","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.freeradbiomed.2007.03.015","article-title":"Soluble RAGE in type 2 diabetes: association with oxidative stress","volume":"43","author":"Devangelio","year":"2007","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.foot.2021.101837_bib0195","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/ndt\/gfn716","article-title":"Asymmetric dimethylarginine is closely associated with the development and progression of nephropathy in patients with type 2 diabetes","volume":"24","author":"Hanai","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.foot.2021.101837_bib0200","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1053\/meta.2003.50048","article-title":"Plasma concen\u00actrations of asymmetric-dimethyl-arginine in type 2 diabetes associate with glycemic control and glomerular filtration rate but not with risk factors of vasculopathy","volume":"52","author":"P\u00e4iv\u00e4","year":"2003","journal-title":"Metabolism"},{"key":"10.1016\/j.foot.2021.101837_bib0205","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.diabres.2009.09.019","article-title":"Role of asymmetric-dimethyl-L-arginine (ADMA) and nitrite \u2044 nitrate (NOx) in the pathogenesis of oxidative stress in female subjects with uncomplicated type 1 diabetes mellitus","volume":"86","author":"Pitocco","year":"2009","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.foot.2021.101837_bib0210","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1475-2840-8-27","article-title":"A study of endothelial function and circulating asymmetric dimethylarginine levels in people with Type 1 diabetes without macrovascular disease or microalbuminuria","volume":"8","author":"Sibal","year":"2009","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.foot.2021.101837_bib0215","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.diabres.2011.01.015","article-title":"Serum asymmetric dimethylarginine levels in diabetic patients with neuropathy","volume":"92","author":"Ya\u015far","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.foot.2021.101837_bib0220","first-page":"183","article-title":"Serum asymmetric dimethylarginine and nitric oxide levels in patients with diabetic neuropathy","volume":"49","author":"Tamam","year":"2012","journal-title":"N\u00f6ropsikiyatri Ar\u015fivi"},{"issue":"1","key":"10.1016\/j.foot.2021.101837_bib0225","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1210\/edrv.22.1.0417","article-title":"Diabetes and endothelial dysfunction: a clinical perspective","volume":"22","author":"Calles-Escandon","year":"2001","journal-title":"Endocr Rev"},{"key":"10.1016\/j.foot.2021.101837_bib0230","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1567-5688(03)00032-1","article-title":"The DDAH ADMA NOS pathway","volume":"4","author":"Tran","year":"2003","journal-title":"Atheroscler"},{"key":"10.1016\/j.foot.2021.101837_bib0235","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1464-5491.2011.03252.x","article-title":"Asymmetric dimethylarginine in young people with Type 1 diabetes: a paradoxical association with HbA1c","volume":"28","author":"Marcovecchio","year":"2011","journal-title":"Diabet Med"},{"key":"10.1016\/j.foot.2021.101837_bib0240","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.amjhyper.2007.07.013","article-title":"Effect of telmisartan on forearm postischemic hyperemia and serum asymmetric dimethylarginine levels","volume":"20","author":"Tomiyama","year":"2007","journal-title":"Am J Hypertens"},{"issue":"4","key":"10.1016\/j.foot.2021.101837_bib0245","article-title":"Asymmetric dimethylarginine (ADMA): an endogenous inhibitor of nitric oxide synthase and a novel cardiovascular risk molecule","volume":"15","author":"Colonna","year":"2009","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.foot.2021.101837_bib0250","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/eurheartj\/ehi876","volume":"27","author":"Yasuda","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.foot.2021.101837_bib0255","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1111\/j.1523-1755.2005.00680.x","article-title":"Plasma asymmetric dimethylarginine (ADMA) concentration is independently associated with carotid intima-media thickness and plasma soluble vascular cell adhesion molecule-1 (sVCAM-1) concentration in patients with mild-to-moderate renal failure","volume":"68","author":"Nanayakkara","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.foot.2021.101837_bib0260","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1291\/hypres.31.1185","article-title":"Plasma level of asymmetric dimethylarginine (ADMA) as a predictor of carotid intima-media thickness progression: six-year prospective study using carotid ultrasonography","volume":"31","author":"Furuki","year":"2008","journal-title":"Hypertens Res"},{"key":"10.1016\/j.foot.2021.101837_bib0265","first-page":"327","article-title":"Plasma concentration of asymmetric Dimethylarginine is correlative to severity of coronary atherosclerosis","volume":"13","author":"Wang","year":"2007","journal-title":"S China J Cadiovasc Dis"},{"key":"10.1016\/j.foot.2021.101837_bib0270","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1161\/01.CIR.99.9.1141","article-title":"Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis","volume":"99","author":"Miyazaki","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.foot.2021.101837_bib0275","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1161\/01.CIR.0000060496.23144.A7","article-title":"Asymmetric dimethylarginine, blood pressure, and renal perfusion in elderly subjects","volume":"107","author":"Kielstein","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.foot.2021.101837_bib0280","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1210\/jcem.86.3.7320","article-title":"Elevated leptin levels are associated with excess gains in fat mass in girls, but not boys, with type 1 diabetes: longitudinal study during adolescence","volume":"86","author":"Ahmed","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.foot.2021.101837_bib0285","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0021-9150(02)00206-X","article-title":"Increased levels of asymmetric dimethylarginine in populations at risk for atherosclerotic disease. Effects of pravastatin","volume":"166","author":"Eid","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.foot.2021.101837_bib0290","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1373\/clinchem.2009.124263","article-title":"Asymmetric dimethylarginine reference intervals determined with tandem mass spectrometry-liquid chromatography: results from the Framingham Offspring cohort","volume":"55","author":"Schwedhelm","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.foot.2021.101837_bib0295","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1161\/01.CIR.95.8.2068","article-title":"Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease","volume":"95","author":"B\u00f6ger","year":"1997","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.foot.2021.101837_bib0300","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1210\/jc.2006-2643","article-title":"Uncomplicated type 1 diabetes is associated with increased asymmetric dimethylarginine concentrations","volume":"92","author":"Altinova","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.foot.2021.101837_bib0305","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.metabol.2004.06.026","article-title":"Relationship between obesity, smoking, and the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine","volume":"53","author":"Eid","year":"2004","journal-title":"Metabolism"},{"key":"10.1016\/j.foot.2021.101837_bib0310","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/00005344-199904000-00020","article-title":"Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetrical dimethylarginine in men with essential hypertension","volume":"33","author":"Surdacki","year":"1999","journal-title":"J Cardiovasc Pharmacol"},{"issue":"3","key":"10.1016\/j.foot.2021.101837_bib0315","doi-asserted-by":"crossref","first-page":"286","DOI":"10.5505\/tjb.2013.43153","article-title":"The relationship between glycemic control and asymmetrical dimethylarginine levels","volume":"38","author":"Madenci","year":"2013","journal-title":"Turk J Biochem"},{"key":"10.1016\/j.foot.2021.101837_bib0320","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.lfs.2004.10.062","article-title":"Effect of diabetic duration on serum concentrations of endogenous inhibitor of nitric oxide synthase in patients and rats with diabetes","volume":"77","author":"Xiong","year":"2005","journal-title":"Life Sci"},{"issue":"11","key":"10.1016\/j.foot.2021.101837_bib0325","first-page":"1508","article-title":"Association of HbA1c, creatinine and lipid profile in patients with diabetic foot ulcer","volume":"16","author":"Hasan","year":"2013","journal-title":"Middle East J Sci Res"},{"key":"10.1016\/j.foot.2021.101837_bib0330","first-page":"205","article-title":"Endothelial dysfunction in hypertension","volume":"13","author":"Taddei","year":"2000","journal-title":"J Nephrol"},{"key":"10.1016\/j.foot.2021.101837_bib0335","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jacc.2005.04.040","article-title":"Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension","volume":"46","author":"Perticone","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.foot.2021.101837_bib0340","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/S0735-1097(99)00065-0","article-title":"Improvement in endothelial function by angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus","volume":"33","author":"O\u2019Driscoll","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.foot.2021.101837_bib0345","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1161\/hy1201.096529","article-title":"Chronic ACE inhibition enhances the endothelial control of arterial mechanics and flow-dependent vasodilatation in heart failure","volume":"38","author":"Joannides","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.foot.2021.101837_bib0350","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/00005344-199504000-00021","article-title":"Effect of longterm angiotensin-converting enzyme inhibition on endothelial function in patients with the insulin-resistance syndrome","volume":"25","author":"Bijlstra","year":"1995","journal-title":"J Cardiovasc Pharmacol"},{"issue":"18","key":"10.1016\/j.foot.2021.101837_bib0355","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1161\/01.CIR.98.18.1842","article-title":"ADMA: a novel risk factor for endothelial dysfunction. Its role in hypercholesterolemia","volume":"98","author":"B\u00f6ger","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.foot.2021.101837_bib0360","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0735-1097(01)01318-3","article-title":"Mild-to-moderate hypertriglyceridemia in young men is associated with endothelial dysfunction and increased plasma concentrations of asymmetric dimethylarginine","volume":"38","author":"Lundman","year":"2001","journal-title":"J Am Coll Cardiol"}],"container-title":["The Foot"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0958259221000638?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0958259221000638?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T09:29:09Z","timestamp":1760693349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0958259221000638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":72,"alternative-id":["S0958259221000638"],"URL":"https:\/\/doi.org\/10.1016\/j.foot.2021.101837","relation":{},"ISSN":["0958-2592"],"issn-type":[{"type":"print","value":"0958-2592"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma levels of Asymmetric Di Methyl Arginine and endothelial dysfunction in diabetic subjects with neuropathic foot ulcer","name":"articletitle","label":"Article Title"},{"value":"The Foot","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.foot.2021.101837","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101837"}}